Solventum (SOLV) Competitors $72.65 -0.24 (-0.32%) Closing price 08/28/2025 03:59 PM EasternExtended Trading$72.50 -0.16 (-0.21%) As of 08/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, IRTC, and TMDXShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies TransMedics Group GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability. Which has preferable earnings & valuation, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.67B1.71$1.99B$4.8815.11Solventum$8.25B1.53$478M$2.1633.64 Does the media favor GEHC or SOLV? In the previous week, Solventum had 1 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 21 mentions for Solventum and 20 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.55 beat Solventum's score of 1.05 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 18 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Solventum 13 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Comparatively, 0.1% of Solventum shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend GEHC or SOLV? GE HealthCare Technologies currently has a consensus price target of $88.55, indicating a potential upside of 20.11%. Solventum has a consensus price target of $85.75, indicating a potential upside of 18.03%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27 Which has more volatility & risk, GEHC or SOLV? GE HealthCare Technologies has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Solventum's net margin of 4.52%. Solventum's return on equity of 29.93% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.22% 23.93% 6.29% Solventum 4.52%29.93%6.65% SummaryGE HealthCare Technologies beats Solventum on 12 of the 16 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.64B$7.69B$5.78B$21.30BDividend YieldN/A2.73%3.95%3.51%P/E Ratio33.6478.2431.2729.34Price / Sales1.5345.60428.4250.88Price / Cash7.3324.7637.7323.86Price / Book3.4621.7310.045.39Net Income$478M$242.04M$3.27B$996.59M7 Day Performance-1.10%-0.92%1.34%0.45%1 Month Performance-1.22%2.64%6.13%3.51%1 Year Performance15.47%9.98%41.90%12.13% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.4943 of 5 stars$72.65-0.3%$85.75+18.0%+21.0%$12.64B$8.25B33.6422,000Positive NewsGEHCGE HealthCare Technologies3.5431 of 5 stars$73.17-0.3%$88.55+21.0%-12.2%$33.41B$19.67B14.9953,000Positive NewsPHGKoninklijke Philips3.4986 of 5 stars$27.47flatN/A-10.1%$26.45B$19.50B144.5866,678Positive NewsZBHZimmer Biomet4.7461 of 5 stars$102.67-0.1%$111.44+8.5%-8.0%$20.34B$7.68B24.9817,000Positive NewsDividend AnnouncementSNNSmith & Nephew SNATS2.9525 of 5 stars$36.29+0.2%$36.00-0.8%+20.1%$15.89B$5.81B16.8017,349Positive NewsPENPenumbra4.7565 of 5 stars$255.35+0.9%$300.47+17.7%+35.5%$9.96B$1.28B67.914,500Positive NewsSTVNStevanato Group1.8058 of 5 stars€22.50-0.5%N/A+16.8%€6.81B€1.19B41.675,521News CoverageGKOSGlaukos4.7261 of 5 stars$89.47-0.4%$127.42+42.4%-28.7%$5.13B$432.95M-54.22780BLCOBausch + Lomb1.1875 of 5 stars$14.49-0.4%$15.56+7.4%-9.5%$5.13B$4.79B-18.5713,500IRTCiRhythm Technologies1.3422 of 5 stars$157.93-1.7%$157.30-0.4%+150.1%$5.07B$591.84M-53.902,000Positive NewsAnalyst ForecastTMDXTransMedics Group2.8863 of 5 stars$125.65-1.5%$123.00-2.1%-30.9%$4.28B$441.54M65.10210Positive News Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives IRTC Alternatives TMDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access